Fempharma is a European, research-driven B2B pharmaceutical company founded in 2016 with a clear mission: to improve women’s health through science-based innovation, particularly in the fields of gynecology and urology.
Our company’s strength lies in its ability to bridge basic and clinical research, translating scientific discoveries into unique healthcare products for women. Our portfolio includes innovative, niche products supported by strong scientific data and compliant with the highest quality standards, including ISO 13485, GMP and ISO 22000.
Today, our products are available in 19 countries. All intellectual property is developed in-house, allowing us to offer proprietary products with extensive medical and scientific backing.
Women’s health SME addressing pelvic-floor dysfunction and menopausal cognitive decline via multisectoral prevention models.
DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
SME offering ready-to-deploy women’s health innovations for public procurement and integrated care pathways.
DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches